Cytek Biosciences, Inc. CTKB EMEA — Total
Other geography segments
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Cytek Biosciences, Inc. in its filing.
Tagged under the XBRL concept us-gaap:NoncurrentAssets.
The official record: Cytek Biosciences, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Cytek Biosciences, Inc.'s emea — total.
Connect your AI assistant and compare segments, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Cytek Biosciences, Inc.'s EMEA — total?
- Cytek Biosciences, Inc. (CTKB) reported EMEA — total of $436K in Q1 2026.
- How has Cytek Biosciences, Inc.'s EMEA — total changed year-over-year?
- Cytek Biosciences, Inc.'s EMEA — total increased by 3.3% year-over-year, from $422K to $436K.
- What does EMEA — total mean?
- This metric captures the aggregate financial performance or total activity volume attributed to the EMEA business segment. It serves as a comprehensive measure of the segment's overall contribution to the company's operational footprint and market presence. By tracking this total, stakeholders can evaluate the scale and relative importance of the EMEA market compared to other global regions.